Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Gold

Showing results (131-140 of 234) with videos related to

Pageof 24
Sort By:
Journal of Drugs in Dermatology : JDD|October 11, 2022
Supplement Individual Article: Algorithm for Pre-/Post-Procedure Measures in Racial/Ethnic Populations Treated With Facial Lasers, Nonenergy Devices, or InjectablesMichael Gold, Andrew Alexis, Anneke Andriessen, et al.
Aesthetic Surgery Journal. Open Forum|March 15, 2024
Efficacy and Safety of LetibotulinumtoxinA in the Treatment of Moderate and Severe Glabellar Lines in Females 35 to 50 Years of Age: Post Hoc Analyses of the Phase 3 Clinical Study DataMichael Gold, Susan Taylor, Daniel S Mueller, et al.
Journal of Cosmetic Dermatology|August 27, 2022
Aesthetic medicine-Quo Vadis?Sebastian Cotofana, Sonja Sattler, Konstantin Frank, et al.
Brain, Behavior, and Immunity|June 21, 2024
Stress and Multiple Sclerosis - Systematic review and meta-analysis of the association with disease onset, relapse risk and disability progressionSönke von Drathen, Stefan Michael Gold, Julia Peper, et al.
Journal of Drugs in Dermatology : JDD|November 4, 2024
Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Participants With Moderate-to-Severe Acne: The Patient JourneyHilary Baldwin, Julie C Harper, Joshua A Zeichner, et al.
Journal of Drugs in Dermatology : JDD|October 7, 2020
IncobotulinumtoxinA Demonstrates Safety and Prolonged Duration of Effect in a Dose-Ranging Study for Glabellar LinesMartina Kerscher, Sabrina Fabi, Tanja Fischer, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|May 26, 2018
Comparison of Hyaluronic Acid Gel With (HARDL) and Without Lidocaine (HAJUP) in the Treatment of Moderate-To-Severe Nasolabial Folds: A Randomized, Evaluator-Blinded StudyLeslie Baumann, Robert A Weiss, Steven Grekin, et al.
Journal of Drugs in Dermatology : JDD|October 12, 2021
IncobotulinumtoxinA Demonstrates Safety and Prolonged Duration of Effect in a Dose-Ranging Study for Glabellar LinesMartina Kerscher, Sabrina Fabi, Tanja Fischer, et al.
Dementia and Geriatric Cognitive Disorders|August 25, 2010
Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III studyMichael Gold, Claire Alderton, Marina Zvartau-Hind, et al.
Aesthetic Surgery Journal|April 18, 2024
Identifying Levels of Competency in Aesthetic Medicine: A Questionnaire-based StudySebastian Cotofana, Tristan Mehta, Kristina Davidovic, et al.
Pageof 24

Showing results (131-140 of 234) with videos related to

Sort By:
Pageof 24
Journal of Drugs in Dermatology : JDD|October 11, 2022
Supplement Individual Article: Algorithm for Pre-/Post-Procedure Measures in Racial/Ethnic Populations Treated With Facial Lasers, Nonenergy Devices, or InjectablesMichael Gold, Andrew Alexis, Anneke Andriessen, et al.
Aesthetic Surgery Journal. Open Forum|March 15, 2024
Efficacy and Safety of LetibotulinumtoxinA in the Treatment of Moderate and Severe Glabellar Lines in Females 35 to 50 Years of Age: Post Hoc Analyses of the Phase 3 Clinical Study DataMichael Gold, Susan Taylor, Daniel S Mueller, et al.
Journal of Cosmetic Dermatology|August 27, 2022
Aesthetic medicine-Quo Vadis?Sebastian Cotofana, Sonja Sattler, Konstantin Frank, et al.
Brain, Behavior, and Immunity|June 21, 2024
Stress and Multiple Sclerosis - Systematic review and meta-analysis of the association with disease onset, relapse risk and disability progressionSönke von Drathen, Stefan Michael Gold, Julia Peper, et al.
Journal of Drugs in Dermatology : JDD|November 4, 2024
Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Participants With Moderate-to-Severe Acne: The Patient JourneyHilary Baldwin, Julie C Harper, Joshua A Zeichner, et al.
Journal of Drugs in Dermatology : JDD|October 7, 2020
IncobotulinumtoxinA Demonstrates Safety and Prolonged Duration of Effect in a Dose-Ranging Study for Glabellar LinesMartina Kerscher, Sabrina Fabi, Tanja Fischer, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|May 26, 2018
Comparison of Hyaluronic Acid Gel With (HARDL) and Without Lidocaine (HAJUP) in the Treatment of Moderate-To-Severe Nasolabial Folds: A Randomized, Evaluator-Blinded StudyLeslie Baumann, Robert A Weiss, Steven Grekin, et al.
Journal of Drugs in Dermatology : JDD|October 12, 2021
IncobotulinumtoxinA Demonstrates Safety and Prolonged Duration of Effect in a Dose-Ranging Study for Glabellar LinesMartina Kerscher, Sabrina Fabi, Tanja Fischer, et al.
Dementia and Geriatric Cognitive Disorders|August 25, 2010
Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III studyMichael Gold, Claire Alderton, Marina Zvartau-Hind, et al.
Aesthetic Surgery Journal|April 18, 2024
Identifying Levels of Competency in Aesthetic Medicine: A Questionnaire-based StudySebastian Cotofana, Tristan Mehta, Kristina Davidovic, et al.
Pageof 24